BNET Industries
Inverness Medical Innovations Inc. (IMA) is in the Pharma Industry
- Revenue
- Dec 31 2007
- $839.5M
- Profit
- Dec 31 2007
- ($241.4M)
- Market Cap
- Aug 19 2008
- $2.7B
Latest News and Analysis
Hedge Fund Tracking: Tremblant Capital
Market Folly submits: Four times a year, hedge funds & asset managers with > $100 million AUM assets under management are required to report to the SEC their holdings from the previous quarter. I check these 13F filings quarterly just to get a sense as to where these funds are...
Inverness Medical Innovations, Inc. Q1 2008 Earnings Call Transcript
Inverness Medical Innovations, Inc. Q1 2008 Earnings Call Transcript
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Inverness Medical Innovations Inc. (AMEX: IMA)
On April 10, 2008, a class action lawsuit was filed in the United States District Court for the District of Massachusetts against Inverness Medical Innovations Inc. (AMEX: IMA). The complaint alleges violations of federal securities laws, Sections 10b and 20a of the Securities Exchange Act of 1934 and Rule...
Inverness Medical Innovations, Inc. Q4 2007 Earnings Call Transcript
Inverness Medical Innovations, Inc. Q4 2007 Earnings Call Transcript
Inverness Medical Innovations Q3 2007 Earnings Call Transcript
Inverness Medical Innovations Q3 2007 Earnings Call Transcript
Inverness sets timetable for acquisition.(PUBLIC COMPANIES)
Inverness Sets Timetable For Acquisition: Inverness Medical Innovations Inc., a Waltham, Mass., medical device manufacturer, officially made its tender offer for all outstanding shares of Biosite Inc. at $92.50 per share in cash May 29. The company w Inverness Sets Timetable For Acquisition: Inverness Medical ...
Inverness Medical wins three-month bidding war for Biosite.(PUBLIC COMPANIES)
If some analysts surmised that the initial offering price for Biosite Inc. was high, they must be perplexed by the bidding war that ensued between two other medical device manufacturers, Beckman Coulter Inc. and eventual winner Inverness Medical Inno If some analysts surmised that the initial...
Marketing of Chembio's Rapid HIV Tests Launched in U.S. by Inverness Medical Innovations, Inc
NEW YORK -- (OTCBB:CEMI) - Chembio's two FDA-approved rapid HIV tests have been launched in the U.S. market and are available exclusively through Inverness Medical Innovations, Inc. (AMEX: IMA) under the Inverness Clearview[R] brand. Chembio is the exclusive manufacturer of these products.
Local company resolves patent infringement suit.(BIOTECH)(Brief article)
Settling A Suit: San Diego-based Acon Laboratories, Inc. has settled a nearly three-year patent infringement battle. The private medical diagnostic company was sued by Waltham, Mass.-based Inverness Medical Innovations, Inc. in 2004 over technology Settling A Suit: San Diego-based Acon Laboratories, Inc. has ...
Leerink Swann & Company Initiates Coverage of Inverness Medical Innovations, Inc. (AMEX: IMA)
This morning, Senior Medical Diagnostics and Supplies Analyst, Bruce Cranna, initiated coverage of Inverness Medical Innovations, Inc. (AMEX: IMA) with a Market Perform rating. His investment rating is based on his belief that investors will appreciate its fast growing point of care diagnostics business more upon the completion of IMA's...
Bernstein Liebhard & Lifshitz, LLP Announces Proposed Settlement and Fairness Hearing of Consumer Class Action Against Inverness Medical Innovations, Inc. and Related Entities
Plaintiff's counsel announce that they have reached a settlement in the class action entitled Sandra Wagner v. Inverness Medical Innovations, et. al., Case No. 03-CV-404-J-20HES, pending in the United States District Court for the Middle District of Florida. The class action has been brought on behalf of all persons...
Additional Resources
*Revised* Analyst Reports for PreMD Inc., Boots & Coots International Well Control Inc., US Dataworks Inc. and Inverness Medical Innovations Inc.
MaybachFinancial.com is one of the fastest growingindependent and unbiased research firms in the world. Through our numerouspartnerships with many of the top investment minds in the world, we provideresearch on companies making a move in the markets. Investors seekinggenuine analyst opinions on their investments for PreMD Inc. (AMEX: PME),Boots &...
Matria Healthcare Provides Critical Support to New Moms Through MaternaLink® Postpartum Depression Screening Program
Of the estimated 4.3 million women giving birth in the U.S. this year, as many as 650,000 of them will suffer from some form of postpartum depression. Yet, less than 40% of women will be diagnosed and less than 15% will receive treatment. Matria is hoping to change that with...
Inverness Medical Innovations Announces Second Quarter 2008 Results
WALTHAM, Mass., July 29 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. , a global leader in rapid point-of-care diagnostic products, today announced its financial results for the quarter ended June 30, 2008. In the second quarter of 2008, the Company recorded net revenue of $401.1 million compared to...
Arbitration Panel Issues Ruling in Distribution Dispute
WALTHAM, Mass., July 25 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. , a leading provider of rapid diagnostic products and health management services, announced that it received today a decision from an arbitration tribunal. That decision, directed at Inverness' Binax subsidiary, awards Binax's distributor in Spain and Portugal approximately...
Inverness Medical Innovations Extends Cardiology Products Distribution Agreement with Thermo Fisher Scientific
WALTHAM, Mass., July 24 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. , a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets today announced that it had reached an agreement with Thermo Fisher Scientific to extend their cardiology products distribution relationship by two years through...
Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET July 29, 2008 to Discuss Second Quarter 2008 Results
WALTHAM, Mass., July 23 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. , a global leader in rapid point-of-care diagnostic products, today announced that it will release its second quarter 2008 earnings on Tuesday, July 29, 2008. The Company will also host a conference call beginning at 10:00 a.m. Eastern Time...
High Growth Reported for the World Smoking Cessation Aids Market
Reportlinker.com announces that a new market research report related to the Personal care industry is available in its catalogue. World Smoking Cessation Aids Market http://www.reportlinker.com/p090576/World-Smoking-Cessation-Aids-Market.html This report analyzes the worldwide markets for Smoking Cessation Aids in US$ Million. The major product segments analyzed are...
Key Challenges and Issues facing the World Immunoassay Instruments Market
Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. World Immunoassay Instruments Market http://www.reportlinker.com/p090674/World-Immunoassay-Instruments-Market.html This report analyzes the worldwide markets for Immunoassay Instruments in Millions of US$. The specific product segments analyzed are Enzyme...
High Growth Forecasted for the World Specialty Enzymes Market
Reportlinker.com announces that a new market research report related to the Chemicals industry industry is available in its catalogue. World Specialty Enzymes Market http://www.reportlinker.com/p090599/World-Specialty-Enzymes-Market.html This report analyzes the worldwide markets for Specialty Enzymes in Millions of US$. The specific product segments analyzed are Specialty...
- Next »
- page 1 of 1
- « Previous
Sort byClose
View by Content TypeClose
View Related Content by Tag Close
- Incorporated: 2001
- CEO: Mr. Ron Zwanziger
Inverness Medical Innovations is a global manufacturer and supplier of rapid diagnostics. Co.'s products and services, as well as its new product development efforts, are focused in the areas of infectious disease, cardiology, oncology, drugs of abuse and women's health. As of Dec 31 2007, Co. had three segments: professional diagnostic, which consists of professional diagnostic products that test for over 100 disease states and conditions; consumer diagnostic, which develops, manufactures, markets and sell consumer diagnostic products outside the cardiology, diabetes and oral care fields; and vitamins and nutritional supplements, which markets vitamins and nutritional supplements.
Key Competitors
Inverness Medical Innovations Inc. Company Info
Board of Directors
Mr. Ron Zwanziger
Chairman
Dr. David Scott Ph.D.
Dr. Jerry McAleer Ph.D.
Ms. Carol R. Goldberg
Mr. Robert P. Khederian
Mr. John F. Levy
Mr. John A. Quelch
Mr. Peter Townsend
Contact Information
51 Sawyer Road
Suite 200
Waltham, MA
http://www.invernessmedical.com
781 647-3900